Product

JR-171

Aliases
JR-171 (lepunafusp alfa)

2 clinical trials

1 indication

Clinical trial
An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I
Status: Active (not recruiting), Estimated PCD: 2025-04-30
Clinical trial
Phase I/II Study of JR-171 ㏌ Patients With Mucopolysaccharidosis Type I
Status: Completed, Estimated PCD: 2022-08-02